ESC 365 - Comparing DOACs and warfarin in atrial fibrillation patients with bioprosthetic valves: a systematic review and meta-analysis

ESC2025 Premium Access

Comparing DOACs and warfarin in atrial fibrillation patients with bioprosthetic valves: a systematic review and meta-analysis

Session: The fear for stroke

Topic: Device Treatment

Speaker: Ms N. Gamarra Valverde (Lima, PE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Norma Gamarra Valverde

Lima (Peru)

1 presentation

0 follower

7 more presentations in this session

Is pre-procedural Transesophageal echocardiography necessary in patients undergoing catheter ablation for atrial fibrillation under uninterrupted anticoagulation?

Speaker: Doctor S. Mohanty (Austin, US)

Role of left atrial appendage occlusion versus direct oral anticoagulants in elderly patients (>80 years) with atrial fibrillation: a retrospective cohort analysis

Speaker: Doctor M. Hunjul (Nablus, PS)

Management of oral anticoagulation after pulsed-field ablation for atrial fibrillation: Insights from a multi-center study

Speaker: Doctor S. Mohanty (Austin, US)

Device-related thrombus post WATCHMAN implantation in the real world: lessons from a prospective multicenter registry of high-volume operators in the US

Speaker: Doctor W. Saliba (Cleveland, US)

Adherence to imaging guidelines post WATCHMAN implantation in the real world: lessons from a multicenter prospective registry of high-volume operators in the US

Speaker: Doctor W. Jaber (Cleveland, US)

Access the full session

The fear for stroke

Speakers: Ms N. Gamarra Valverde, Doctor S. Mohanty, Doctor M. Hunjul, Doctor S. Mohanty, Doctor W. Saliba...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources